Search

Despite the proven benefits of exercise, even while receiving cancer treatment, new research undertaken by Memorial Sloan Kettering’s Integrative Medicine Service, shows that the majority of cancer patients report significant decreases in their physical activity levels after their cancer diagnosis.

… Wednesday, February 15, 2017 Despite the proven benefits of exercise, even while receiving treatments, new research from Memorial Sloan Kettering’s Integrative Medicine Service shows that the majority of cancer patients report significant decreases in their physical activity levels after their cancer

A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe.

… Thursday, December 1, 2011 Summary A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe. An expert on minimally invasive laser surgery, Snehal G.

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Selwyn M. Vickers, MD, President and CEO of MSK, is among 30 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2024.

… Friday, January 12, 2024 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Selwyn M. Vickers, MD, President and CEO of MSK, is among 30 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2024

Craig B. Thompson announced his intention to step down as President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center and has asked the Boards of Trustees and Governing Trustees to begin a search for his successor.

… Thursday, February 3, 2022 Today, Craig B. Thompson announced his intention to step down as President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center (MSK) and has asked the Boards of Trustees and Governing Trustees to begin a search for his successor. Thompson will continue in

Scientists have uncovered a surprising link between metabolism and gene control in T cells.

… Monday, November 7, 2016 Summary New research by scientists at the Sloan Kettering Institute finds a surprising link between metabolism and gene expression in T cells, raising implications for the treatment of cancer and autoimmune diseases. Highlights Immune cells use a form of metabolism called aerobic

Researchers at Memorial Sloan Kettering Cancer Center have shown for the first time that a tendency to develop some blood disorders may be inherited.

… Sunday, March 15, 2009 Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) have shown for the first time that a tendency to develop some blood disorders may be inherited. Their research, published online today in Nature Genetics , identifies a common genetic sequence abnormality that enhances

MSK doctors, such as Julia Glade Bender, are achieving better outcomes for patients by personalizing treatment on the basis of the biology of the cancer rather than the patient’s age.

… Friday, October 1, 2021 Memorial Sloan Kettering Cancer Center pediatric oncologist Julia Glade Bender recalls very clearly the event that sparked her interest in improving care for adolescents and young adults with cancer. She was treating children with cancer at another New York City medical center

For the past 27 years the MSK Facilities Team has created a beautiful holiday wonderland to spread cheer to staff and patients alike. This year, Santa’s MSK helpers came to the rescue in more ways than one.

… Monday, December 21, 2020 VIDEO | 02:06 2020 Holiday Hallway Montage Take a Tour of MSK's Holiday Hallway Video Details For the past 27 years, if you strolled into Memorial Sloan Kettering’s basement corridor during December, you would find the MSK Facilities Team, including carpenters, plumbers, locksmiths

A drug effective in all cancer types with a mutation called a TRK fusion could be the first ever developed simultaneously in adults and children.

… Saturday, June 3, 2017 Summary Previous therapies targeting specific genetic mutations have had mixed results across different cancer types. A new drug, larotrectinib, appears to work in all cancers with a mutation called a TRK fusion. These results are potentially practice changing. The success of precision

Learn how pre-health students at Hunter College can get a feel for a career at MSK.

… Tuesday, July 13, 2021 Asha Ewrse thought she wanted to be an English major. But as she explored future career options, she realized something. “Over time, my focus became less about books themselves and more about the people — the minds and souls that serve as the foundation of any art form,” says Ms